A Feasibility Study in Chronically Fatigued Cancer Survivors
Primary Purpose
Fatigue, Lymphoma
Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
A 12-week interdisciplinary complex intervention
Sponsored by
About this trial
This is an interventional other trial for Fatigue focused on measuring exercise, chronic fatigue, lymphoma, cancer survivors, nutrition, cognitive therapy, patient education
Eligibility Criteria
Seven lymphoma survivors will be included, with the same inclusion criteria as in the planned RCT:
Inclusion Criteria:
- Survivors of Hodgkin and aggressive non-Hodgkin lymphoma, diagnosed 2014 or 2019 (n=7)
- 18-65 years at diagnosis, and 19-67 years at participation.
- CF measured by Chalder FQ.
- Curatively treated, more than 2 years since last treatment.
- Participation approval from oncologist.
Exclusion Criteria:
- Indolent non-Hodgkin lymphoma.
- Fatigue more than one year before the cancer diagnosis.
- Ongoing cancer treatment, relapse or second cancer, somatic/physical conditions (i.e. severe heart failure/disease, lung disease, use of wheelchair /crutches).
- Psychiatric disorders (i.e. severe depression, schizophrenia), substance abuse disorder.
In addition, eight cancer survivors with various diagnosis, will be included from a waiting list for rehabilitation at the Cancer Rehabilitation Centre at Aker hospital.
Sites / Locations
- Oslo University Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Interdisciplinary complex intervention
Arm Description
The intervention includes patient education, physical exercise, a group-based cognitive behavioral program and individual nutritional counseling
Outcomes
Primary Outcome Measures
Recruitment rate
Assessed by the number who consent to participate
Inclusion rate
Assessed by the number of consenting participants who are included (i.e. have chronic fatigue according to the Fatigue Questionnaire, and are cleared for participation by oncologist after the medical screening).
Completion rate
Assessed by the number of consenting participants consenting patients who complete any measurement at the final assessment
Strengths and weaknesses with the inclusion procedure: participants
Assessed by structured conversations with the participants
Strengths and weaknesses with the inclusion procedure: study personnel
Assessed by structured conversations with the study personnel
Feasibility of the patient education session: participants
Strengths, weaknesses, and usefulness of the contents in the education session will be assessed by structured conversations with the participants after the patient education session.
Feasibility of the patient education session: presenters
Strengths, weaknesses, and usefulness of the contents in the education session will be assessed by structured conversations with the presenters after the patient education session.
Feasibility of the exercise program part one (week 1-3): participants
Strengths and weaknesses with the exercise program will be evaluated through structured conversations with the participants
Feasibility of the exercise program part one (week 1-3): physiotherapists
Strengths and weaknesses with the exercise program will be evaluated through structured conversations with the physiotherapists
Feasibility of the exercise program part two (week 4-7): participants
Strengths and weaknesses with the exercise program will be evaluated through structured conversations with the participants
Feasibility of the exercise program part two (week 4-7): physiotherapists
Strengths and weaknesses with the exercise program will be evaluated through structured conversations with the physiotherapists
Compliance to the cognitive behavioral therapy groups sessions
Participation to the cognitive behavioral therapy groups sessions will be registered by the study coordinators/psychologists..
Feasibility of the cognitive behavioral therapy groups sessions: participants
Strengths, weaknesses, and usefulness of the groups sessions will be assessed by structured conversations with the participants after the last group session
Feasibility of the cognitive behavioral therapy groups sessions: psychologists
Strengths, weaknesses, and usefulness of the groups sessions will be assessed by structured conversations with the psychologists after the last group session
Compliance to the nutrition counseling
Participation rate of the individual nutrition counseling sessions will be registered by the clinical dietitian.
Feasibility of the nutrition counseling: participants
Strengths, weaknesses, and usefulness of the contents in the sessions will be assessed by structured conversations with the participants after the last counseling session.
Feasibility of the nutrition counseling: clinical dietitian
Strengths, weaknesses, and usefulness of the contents in the sessions will be assessed by structured conversations with the clinical dietitian after the last counseling session.
Compliance to the exercise program: attendance
Registered by the physiotherapists in an exercise log
Compliance to the exercise program: intensity during the aerobic exercise intervals
Registered by pulse sensors
Compliance to the exercise program: implementation of the strength training exercises
Registered by the physiotherapists in an exercise log
Feasibility of the exercise program part three (week 8-12): participants
Strengths and weaknesses with the exercise program will be evaluated through structured conversations with the participants
Feasibility of the exercise program part three (week 8-12): physiotherapists
Strengths and weaknesses with the exercise program will be evaluated through structured conversations with the physiotherapists
Feasibility of the questionnaires
Strengths and weaknesses with the questionnaire will be evaluated through structured conversations with the participants.
Feasibility of the physical tests: participants
Strengths and weaknesses with the tests will be evaluated through structured conversations with the participants.
Feasibility of the physical tests: physiotherapists
Strengths and weaknesses with the tests will be evaluated through structured conversations with the physiotherapists conducting the tests.
Compliance to the physical tests
Assessed by the completion rate of the physical tests (i.e. the number of participants who conduct the tests as planned).
Completeness of the questionnaires
Assessed by the completion rate of the questionnaire (i.e. proportion of missing).
Secondary Outcome Measures
Change in level of fatigue
Measured by Chalder Fatigue Questionnaire. Total score range from 0 to 33, with increasing score implying more fatigue.
Change in level of fatigue
Measured by Chalder Fatigue Questionnaire. Total score range from 0 to 33, with increasing score implying more fatigue.
Change in level of fatigue
Measured by Chalder Fatigue Questionnaire. Total score range from 0 to 33, with increasing score implying more fatigue.
Change in daily functioning and global quality of life
Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC-QLQ-C30). Scores range fro 0 to 100, a higher score represents a higher (better) level of functioning or a higher (worse) level of symptoms.
Change in daily functioning and global quality of life
Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC-QLQ-C30). Scores range fro 0 to 100, a higher score represents a higher (better) level of functioning or a higher (worse) level of symptoms.
Change in daily functioning and global quality of life
Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC-QLQ-C30). Scores range fro 0 to 100, a higher score represents a higher (better) level of functioning or a higher (worse) level of symptoms.
Change in subjective well-being
Measured by the Satisfaction with Life Scale. Total score range from 5 to 35, with increasing score implying higher subjective well-being.
Change in vitality
Measured by the Subjective Vitality Scale. The total score ranges from 6 to 36 with a higher score indicating a better condition
Change in general health
Measured by European Quality of Life Five-dimension Scale Questionnaire (EQ-5D). Total score range from 5 (worst health) to 25 (best health).
Change in work ability
Measured by Work Ability Index. Total score range from 7 to 49 points, with higher score indicating better work ability.
Change in work ability
Measured by Work Ability Index. Total score range from 7 to 49 points, with higher score indicating better work ability.
Change in work ability
Measured by Work Ability Index. Total score range from 7 to 49 points, with higher score indicating better work ability.
Change in anxiety symptoms
Measured by the General Anxiety Disorder 7-items. Total score range from 0 to 21 with increasing score implying higher level of anxiety.
Change in anxiety symptoms
Measured by the General Anxiety Disorder 7-items. Total score range from 0 to 21 with increasing score implying higher level of anxiety.
Change in anxiety symptoms
Measured by the General Anxiety Disorder 7-items. Total score range from 0 to 21 with increasing score implying higher level of anxiety.
Change in depressive symptoms
Measured by the Patient Health Questionnaire-9. Total score from 0 to 27, increasing score implying higher depressive symptoms.
Change in depressive symptoms
Measured by the Patient Health Questionnaire-9. Total score from 0 to 27, increasing score implying higher depressive symptoms.
Change in depressive symptoms
Measured by the Patient Health Questionnaire-9. Total score from 0 to 27, increasing score implying higher depressive symptoms.
Change in level of physical activity
Measured by the Godin Leisure Time Exercise Questionnaire
Change in level of physical activity
Measured by the Godin Leisure Time Exercise Questionnaire
Change in level of physical activity
Measured by the Godin Leisure Time Exercise Questionnaire
Change in exercise mastery
Assessed by the Perceived Competence Scale. The scale consists of 4 items (statements). On each item, participants are asked to rate how true a statement is using a 7-point scale.Total score range from 4 to 28, with increasing score reflecting higher exercise mastery.
Change in exercise mastery
Assessed by the Perceived Competence Scale. The scale consists of 4 items (statements). On each item, participants are asked to rate how true a statement is using a 7-point scale.Total score range from 4 to 28, with increasing score reflecting higher exercise mastery.
Change in exercise mastery
Assessed by the Perceived Competence Scale. The scale consists of 4 items (statements). On each item, participants are asked to rate how true a statement is using a 7-point scale.Total score range from 4 to 28, with increasing score reflecting higher exercise mastery.
Change in dietary intake of the participants
Measured by a digital food frequency questionnaire (DIGIKOST-FFQ)
Change in meal pattern
Measured by the Meal Pattern Questionnaire
Change in body mass index
Calculated by measuring weight and height
Change in body mass index
Calculated by measuring weight and height
Change in body mass index
Calculated by measuring weight and height
Change in sleep problems
Measured by questions from the Trøndelag Health Survey
Change in sleep problems
Measured by questions from the Trøndelag Health Survey
Change in sleep problems
Measured by questions from the Trøndelag Health Survey
Change in cardiorespiratory fitness
Assessed by a submaximal and indirect treadmill test (modified Balke protocol)
Change in cardiorespiratory fitness
Assessed by a submaximal and indirect treadmill test (modified Balke protocol)
Change in cardiorespiratory fitness
Assessed by a submaximal and indirect treadmill test (modified Balke protocol)
Change in lower body muscle strength
Assessed by 30 second sit-to-stand test
Change in lower body muscle strength
Assessed by 30 second sit-to-stand test
Change in lower body muscle strength
Assessed by 30 second sit-to-stand test
Change in upper body muscle strength
Assessed by maximum repetitions of push-ups with various starting positions
Change in upper body muscle strength
Assessed by maximum repetitions of push-ups with various starting positions
Change in upper body muscle strength
Assessed by maximum repetitions of push-ups with various starting positions
Change in quality of life among relatives
Assessed by the Research and Development 36-item Short Form Survey (RAND SF-36).The eight scales are standardized with a scoring algorithm or by the SF-36v2 scoring software to obtain a score ranging from 0 to 100. Higher scores indicate better quality of life.
Change in global health status among relatives
The global health status / quality of life scale from the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC-QLQ-C30). Scores range from 0 to 100, a higher score represents a higher (better) level of functioning or a higher (worse) level of symptoms.
Full Information
NCT ID
NCT04931407
First Posted
April 16, 2021
Last Updated
April 20, 2022
Sponsor
Oslo University Hospital
Collaborators
University of Oslo, Diakonhjemmet Hospital, Norwegian School of Sport Sciences, Norwegian University of Science and Technology, University of Alberta, UiT The Arctic University of Norway
1. Study Identification
Unique Protocol Identification Number
NCT04931407
Brief Title
A Feasibility Study in Chronically Fatigued Cancer Survivors
Official Title
A Feasibility Study in Chronically Fatigued Cancer Survivors
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
April 6, 2021 (Actual)
Primary Completion Date
January 31, 2022 (Actual)
Study Completion Date
January 31, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Oslo University Hospital
Collaborators
University of Oslo, Diakonhjemmet Hospital, Norwegian School of Sport Sciences, Norwegian University of Science and Technology, University of Alberta, UiT The Arctic University of Norway
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Improved cancer survival has led to increased attention on long-term health and quality of life (QoL) among the survivors. Both the cancer diagnosis and intensive treatments increase the risk of late effects which may interfere with daily physical, psychological and social functioning, and thereby negatively affect their QoL. Well-documented late-effects among cancer survivors are second cancer, cardio-vascular disease, pain, hormone disturbances, mental distress and chronic fatigue (CF).
CF is a subjective experience of substantial lack of energy, exhaustion and cognitive difficulties lasting for six months or longer. CF is one of the most common and distressing late effects after cancer, affecting 15-35 % of survivors, often for years beyond treatment. Despite the high prevalence and the huge negative consequences of CF on daily functioning and QoL and the economic and societal costs, effective treatment of CF and standardized follow-up care are currently lacking.
CF is a complex condition best understood as a multifactorial phenomenon. Our and other research groups have examined various cohorts of cancer survivors in order to identify behavioral-, psychological-, and biological factors associated with CF, that can form the basis for targeted interventions. So far, few treatable biological factors have been identified, even though immune activation, flattened diurnal cortisol slopes and a blunted cortisol response to stress have been demonstrated in small studies among cancer survivors suffering from CF. On the other hand, several modifiable behavioral factors including emotional distress, physical inactivity, sleep disturbances and unhealthy diets are found to be associated with CF. So far, most of the interventions aiming to reduce fatigue during and shortly after cancer treatment have targeted only one of these factors at a time, with small to moderate effect sizes. No prior study has examined if CF in cancer survivors is better treated by a complex intervention targeting combinations of these factors, an approach which seems logical due to the complexity of the symptom.
The Division of Cancer Medicine at Oslo University Hospital (OUH) presently offers limited rehabilitation programs, including patient education, physical exercise, cognitive behavioral program and nutrition counselling to cancer survivors with CF. However, these programs are not offered as an interdisciplinary intervention integrated in a standardized patient care pathway, and the effects of these interventions have not been assessed. Based on the investigators clinical experience and published studies on single-targeted interventions, the investigators hypothesize that a complex intervention including psycho-educational elements, physical exercise and nutrition counseling delivered as a standardized patient care pathway is well-founded and doable, and will improve fatigue, functioning and QoL in cancer survivors with CF.
During the fall of 2021, the investigators will conduct a randomized controlled trial (RCT) with the overall objective to improve fatigue in lymphoma survivors with CF. To uncover strengths and weaknesses with the planned RCT, i.e. the inclusion procedures, the assessments and the complex intervention, the investigators are now conducting a small one-armed feasibility study before the RCT during spring 2021.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fatigue, Lymphoma
Keywords
exercise, chronic fatigue, lymphoma, cancer survivors, nutrition, cognitive therapy, patient education
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Interdisciplinary complex intervention
Arm Type
Experimental
Arm Description
The intervention includes patient education, physical exercise, a group-based cognitive behavioral program and individual nutritional counseling
Intervention Type
Other
Intervention Name(s)
A 12-week interdisciplinary complex intervention
Intervention Description
The intervention will last for 12 weeks and includes four components; patient education, physical exercise, cognitive behavioral program and nutritional counseling.
The patient education will include an online 2-hours group-based patient-education sessions in week 1.
The physical exercise program includes two weekly exercise sessions, one supervised by a physiotherapist and one unsupervised, including aerobic exercise, resistance exercise and psychometric physiotherapy. Half of the intervention group (N=7) will perform the supervised exercise session individually with a physiotherapist in the municipality, while the other half (n=8) will exercise in online groups lead by physiotherapists.
The cognitive behavioral program will begin in week 3 and include six group-based online sessions every week lead by a clinical psychologist.
The nutritional counseling will include three individual digital nutrition counselling sessions in week 2, 6 and 10 by a clinical dietitian.
Primary Outcome Measure Information:
Title
Recruitment rate
Description
Assessed by the number who consent to participate
Time Frame
The week before the intervention period (week 0)
Title
Inclusion rate
Description
Assessed by the number of consenting participants who are included (i.e. have chronic fatigue according to the Fatigue Questionnaire, and are cleared for participation by oncologist after the medical screening).
Time Frame
The week before the intervention period (week 0)
Title
Completion rate
Description
Assessed by the number of consenting participants consenting patients who complete any measurement at the final assessment
Time Frame
The week before the intervention period (week 0)
Title
Strengths and weaknesses with the inclusion procedure: participants
Description
Assessed by structured conversations with the participants
Time Frame
Week 4
Title
Strengths and weaknesses with the inclusion procedure: study personnel
Description
Assessed by structured conversations with the study personnel
Time Frame
Week 4
Title
Feasibility of the patient education session: participants
Description
Strengths, weaknesses, and usefulness of the contents in the education session will be assessed by structured conversations with the participants after the patient education session.
Time Frame
Week 4
Title
Feasibility of the patient education session: presenters
Description
Strengths, weaknesses, and usefulness of the contents in the education session will be assessed by structured conversations with the presenters after the patient education session.
Time Frame
Week 4
Title
Feasibility of the exercise program part one (week 1-3): participants
Description
Strengths and weaknesses with the exercise program will be evaluated through structured conversations with the participants
Time Frame
Week 4
Title
Feasibility of the exercise program part one (week 1-3): physiotherapists
Description
Strengths and weaknesses with the exercise program will be evaluated through structured conversations with the physiotherapists
Time Frame
Week 4
Title
Feasibility of the exercise program part two (week 4-7): participants
Description
Strengths and weaknesses with the exercise program will be evaluated through structured conversations with the participants
Time Frame
Week 8
Title
Feasibility of the exercise program part two (week 4-7): physiotherapists
Description
Strengths and weaknesses with the exercise program will be evaluated through structured conversations with the physiotherapists
Time Frame
Week 8
Title
Compliance to the cognitive behavioral therapy groups sessions
Description
Participation to the cognitive behavioral therapy groups sessions will be registered by the study coordinators/psychologists..
Time Frame
Week 8
Title
Feasibility of the cognitive behavioral therapy groups sessions: participants
Description
Strengths, weaknesses, and usefulness of the groups sessions will be assessed by structured conversations with the participants after the last group session
Time Frame
Week 8
Title
Feasibility of the cognitive behavioral therapy groups sessions: psychologists
Description
Strengths, weaknesses, and usefulness of the groups sessions will be assessed by structured conversations with the psychologists after the last group session
Time Frame
Week 8
Title
Compliance to the nutrition counseling
Description
Participation rate of the individual nutrition counseling sessions will be registered by the clinical dietitian.
Time Frame
Week 11
Title
Feasibility of the nutrition counseling: participants
Description
Strengths, weaknesses, and usefulness of the contents in the sessions will be assessed by structured conversations with the participants after the last counseling session.
Time Frame
Week 11
Title
Feasibility of the nutrition counseling: clinical dietitian
Description
Strengths, weaknesses, and usefulness of the contents in the sessions will be assessed by structured conversations with the clinical dietitian after the last counseling session.
Time Frame
Week 11
Title
Compliance to the exercise program: attendance
Description
Registered by the physiotherapists in an exercise log
Time Frame
Week 13
Title
Compliance to the exercise program: intensity during the aerobic exercise intervals
Description
Registered by pulse sensors
Time Frame
Week 13
Title
Compliance to the exercise program: implementation of the strength training exercises
Description
Registered by the physiotherapists in an exercise log
Time Frame
Week 13
Title
Feasibility of the exercise program part three (week 8-12): participants
Description
Strengths and weaknesses with the exercise program will be evaluated through structured conversations with the participants
Time Frame
Week 13
Title
Feasibility of the exercise program part three (week 8-12): physiotherapists
Description
Strengths and weaknesses with the exercise program will be evaluated through structured conversations with the physiotherapists
Time Frame
Week 13
Title
Feasibility of the questionnaires
Description
Strengths and weaknesses with the questionnaire will be evaluated through structured conversations with the participants.
Time Frame
Week 13
Title
Feasibility of the physical tests: participants
Description
Strengths and weaknesses with the tests will be evaluated through structured conversations with the participants.
Time Frame
Week 13
Title
Feasibility of the physical tests: physiotherapists
Description
Strengths and weaknesses with the tests will be evaluated through structured conversations with the physiotherapists conducting the tests.
Time Frame
Week 13
Title
Compliance to the physical tests
Description
Assessed by the completion rate of the physical tests (i.e. the number of participants who conduct the tests as planned).
Time Frame
Week 13
Title
Completeness of the questionnaires
Description
Assessed by the completion rate of the questionnaire (i.e. proportion of missing).
Time Frame
Week 13
Secondary Outcome Measure Information:
Title
Change in level of fatigue
Description
Measured by Chalder Fatigue Questionnaire. Total score range from 0 to 33, with increasing score implying more fatigue.
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in level of fatigue
Description
Measured by Chalder Fatigue Questionnaire. Total score range from 0 to 33, with increasing score implying more fatigue.
Time Frame
Change from baseline (week 0) to 4 months follow-up (week 29)
Title
Change in level of fatigue
Description
Measured by Chalder Fatigue Questionnaire. Total score range from 0 to 33, with increasing score implying more fatigue.
Time Frame
Change from baseline (week 0) to 7 months follow-up (week 42)
Title
Change in daily functioning and global quality of life
Description
Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC-QLQ-C30). Scores range fro 0 to 100, a higher score represents a higher (better) level of functioning or a higher (worse) level of symptoms.
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in daily functioning and global quality of life
Description
Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC-QLQ-C30). Scores range fro 0 to 100, a higher score represents a higher (better) level of functioning or a higher (worse) level of symptoms.
Time Frame
Change from baseline (week 0) to 4 months follow-up (week 29)
Title
Change in daily functioning and global quality of life
Description
Measured by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC-QLQ-C30). Scores range fro 0 to 100, a higher score represents a higher (better) level of functioning or a higher (worse) level of symptoms.
Time Frame
Change from baseline (week 0) to 7 months follow-up (week 42)
Title
Change in subjective well-being
Description
Measured by the Satisfaction with Life Scale. Total score range from 5 to 35, with increasing score implying higher subjective well-being.
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in vitality
Description
Measured by the Subjective Vitality Scale. The total score ranges from 6 to 36 with a higher score indicating a better condition
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in general health
Description
Measured by European Quality of Life Five-dimension Scale Questionnaire (EQ-5D). Total score range from 5 (worst health) to 25 (best health).
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in work ability
Description
Measured by Work Ability Index. Total score range from 7 to 49 points, with higher score indicating better work ability.
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in work ability
Description
Measured by Work Ability Index. Total score range from 7 to 49 points, with higher score indicating better work ability.
Time Frame
Change from baseline (week 0) to 4 months follow-up (week 29)
Title
Change in work ability
Description
Measured by Work Ability Index. Total score range from 7 to 49 points, with higher score indicating better work ability.
Time Frame
Change from baseline (week 0) to 7 months follow-up (week 42)
Title
Change in anxiety symptoms
Description
Measured by the General Anxiety Disorder 7-items. Total score range from 0 to 21 with increasing score implying higher level of anxiety.
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in anxiety symptoms
Description
Measured by the General Anxiety Disorder 7-items. Total score range from 0 to 21 with increasing score implying higher level of anxiety.
Time Frame
Change from baseline (week 0) to 4 months follow-up (week 29)
Title
Change in anxiety symptoms
Description
Measured by the General Anxiety Disorder 7-items. Total score range from 0 to 21 with increasing score implying higher level of anxiety.
Time Frame
Change from baseline (week 0) to 7 months follow-up (week 42)
Title
Change in depressive symptoms
Description
Measured by the Patient Health Questionnaire-9. Total score from 0 to 27, increasing score implying higher depressive symptoms.
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in depressive symptoms
Description
Measured by the Patient Health Questionnaire-9. Total score from 0 to 27, increasing score implying higher depressive symptoms.
Time Frame
Change from baseline (week 0) to 4 months follow-up (week 29)
Title
Change in depressive symptoms
Description
Measured by the Patient Health Questionnaire-9. Total score from 0 to 27, increasing score implying higher depressive symptoms.
Time Frame
Change from baseline (week 0) to 7 months follow-up (week 42)
Title
Change in level of physical activity
Description
Measured by the Godin Leisure Time Exercise Questionnaire
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in level of physical activity
Description
Measured by the Godin Leisure Time Exercise Questionnaire
Time Frame
Change from baseline (week 0) to 4 months follow-up (week 29)
Title
Change in level of physical activity
Description
Measured by the Godin Leisure Time Exercise Questionnaire
Time Frame
Change from baseline (week 0) to 7 months follow-up (week 42)
Title
Change in exercise mastery
Description
Assessed by the Perceived Competence Scale. The scale consists of 4 items (statements). On each item, participants are asked to rate how true a statement is using a 7-point scale.Total score range from 4 to 28, with increasing score reflecting higher exercise mastery.
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in exercise mastery
Description
Assessed by the Perceived Competence Scale. The scale consists of 4 items (statements). On each item, participants are asked to rate how true a statement is using a 7-point scale.Total score range from 4 to 28, with increasing score reflecting higher exercise mastery.
Time Frame
Change from baseline (week 0) to 4 months follow-up (week 29)
Title
Change in exercise mastery
Description
Assessed by the Perceived Competence Scale. The scale consists of 4 items (statements). On each item, participants are asked to rate how true a statement is using a 7-point scale.Total score range from 4 to 28, with increasing score reflecting higher exercise mastery.
Time Frame
Change from baseline (week 0) to 7 months follow-up (week 42)
Title
Change in dietary intake of the participants
Description
Measured by a digital food frequency questionnaire (DIGIKOST-FFQ)
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in meal pattern
Description
Measured by the Meal Pattern Questionnaire
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in body mass index
Description
Calculated by measuring weight and height
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in body mass index
Description
Calculated by measuring weight and height
Time Frame
Change from baseline (week 0) to 4 months follow-up (week 29)
Title
Change in body mass index
Description
Calculated by measuring weight and height
Time Frame
Change from baseline (week 0) to 7 months follow-up (week 42)
Title
Change in sleep problems
Description
Measured by questions from the Trøndelag Health Survey
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in sleep problems
Description
Measured by questions from the Trøndelag Health Survey
Time Frame
Change from baseline (week 0) to 4 months follow-up (week 29)
Title
Change in sleep problems
Description
Measured by questions from the Trøndelag Health Survey
Time Frame
Change from baseline (week 0) to 7 months follow-up (week 42)
Title
Change in cardiorespiratory fitness
Description
Assessed by a submaximal and indirect treadmill test (modified Balke protocol)
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in cardiorespiratory fitness
Description
Assessed by a submaximal and indirect treadmill test (modified Balke protocol)
Time Frame
Change from baseline (week 0) to 4 months follow-up (week 29)
Title
Change in cardiorespiratory fitness
Description
Assessed by a submaximal and indirect treadmill test (modified Balke protocol)
Time Frame
Change from baseline (week 0) to 7 months follow-up (week 42)
Title
Change in lower body muscle strength
Description
Assessed by 30 second sit-to-stand test
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in lower body muscle strength
Description
Assessed by 30 second sit-to-stand test
Time Frame
Change from baseline (week 0) to 4 months follow-up (week 29)
Title
Change in lower body muscle strength
Description
Assessed by 30 second sit-to-stand test
Time Frame
Change from baseline (week 0) to 7 months follow-up (week 42)
Title
Change in upper body muscle strength
Description
Assessed by maximum repetitions of push-ups with various starting positions
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in upper body muscle strength
Description
Assessed by maximum repetitions of push-ups with various starting positions
Time Frame
Change from baseline (week 0) to 4 months follow-up (week 29)
Title
Change in upper body muscle strength
Description
Assessed by maximum repetitions of push-ups with various starting positions
Time Frame
Change from baseline (week 0) to 7 months follow-up (week 42)
Title
Change in quality of life among relatives
Description
Assessed by the Research and Development 36-item Short Form Survey (RAND SF-36).The eight scales are standardized with a scoring algorithm or by the SF-36v2 scoring software to obtain a score ranging from 0 to 100. Higher scores indicate better quality of life.
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
Title
Change in global health status among relatives
Description
The global health status / quality of life scale from the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC-QLQ-C30). Scores range from 0 to 100, a higher score represents a higher (better) level of functioning or a higher (worse) level of symptoms.
Time Frame
Change from baseline (week 0) and to post-intervention (week 13)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
19 Years
Maximum Age & Unit of Time
67 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Seven lymphoma survivors will be included, with the same inclusion criteria as in the planned RCT:
Inclusion Criteria:
Survivors of Hodgkin and aggressive non-Hodgkin lymphoma, diagnosed 2014 or 2019 (n=7)
18-65 years at diagnosis, and 19-67 years at participation.
CF measured by Chalder FQ.
Curatively treated, more than 2 years since last treatment.
Participation approval from oncologist.
Exclusion Criteria:
Indolent non-Hodgkin lymphoma.
Fatigue more than one year before the cancer diagnosis.
Ongoing cancer treatment, relapse or second cancer, somatic/physical conditions (i.e. severe heart failure/disease, lung disease, use of wheelchair /crutches).
Psychiatric disorders (i.e. severe depression, schizophrenia), substance abuse disorder.
In addition, eight cancer survivors with various diagnosis, will be included from a waiting list for rehabilitation at the Cancer Rehabilitation Centre at Aker hospital.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lene Thorsen
Organizational Affiliation
Oslo University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Oslo University Hospital
City
Oslo
ZIP/Postal Code
0379
Country
Norway
12. IPD Sharing Statement
Learn more about this trial
A Feasibility Study in Chronically Fatigued Cancer Survivors
We'll reach out to this number within 24 hrs